blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0587255

EP0587255 - Insulinotropic hormone [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  01.10.2004
Database last updated on 14.05.2024
Most recent event   Tooltip05.10.2005Change: Appeal number 
Applicant(s)For all designated states
THE GENERAL HOSPITAL CORPORATION
55 Fruit Street
Boston, MA 02114 / US
[N/P]
Former [1994/11]For all designated states
THE GENERAL HOSPITAL CORPORATION
55 Fruit Street
Boston, MA 02114 / US
Inventor(s)01 / Habener, Joel
217 Plymouth Road
Newton Highlands, Massachusetts 02161 / US
[1994/11]
Representative(s)Thomas, Philip John Duval, et al
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Former [2002/16]Thomas, Philip John Duval, et al
Eric Potter Clarkson, Park View House, 58 The Ropewalk
Nottingham NG1 5DD / GB
Former [1998/47]Chapman, Paul William, et al
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Former [1994/11]Wright, Simon Mark, et al
Kilburn & Strode 30 John Street
London WC1N 2DD / GB
Application number, filing date93203087.705.05.1987
[1994/11]
Priority number, dateUS1986085992805.05.1986         Original published format: US 859928
[1994/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0587255
Date:16.03.1994
Language:EN
[1994/11]
Search report(s)(Supplementary) European search report - dispatched on:EP29.12.1993
ClassificationIPC:C07K7/10, C07K7/34, A61K37/02, A61K37/28
[1994/11]
CPC:
A61K38/26 (EP); A61P3/08 (EP); C07K14/605 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1994/11]
TitleGerman:Insulinotropische Hormone[1994/11]
English:Insulinotropic hormone[1994/11]
French:Hormone insulinotropique[1994/11]
Examination procedure11.11.1993Examination requested  [1994/11]
15.02.1995Despatch of a communication from the examining division (Time limit: M04)
16.06.1995Reply to a communication from the examining division
16.02.1996Despatch of a communication from the examining division (Time limit: M06)
06.08.1996Reply to a communication from the examining division
17.04.1997Despatch of a communication from the examining division (Time limit: M06)
24.10.1997Reply to a communication from the examining division
18.09.1998Despatch of a communication from the examining division (Time limit: M06)
26.03.1999Reply to a communication from the examining division
21.06.1999Despatch of a communication from the examining division (Time limit: M02)
23.08.1999Reply to a communication from the examining division
21.09.1999Observations by third parties
05.07.2000Despatch of a communication from the examining division (Time limit: M06)
03.01.2001Reply to a communication from the examining division
22.05.2001Observations by third parties
23.10.2001Date of oral proceedings
20.11.2001Despatch of communication that the application is refused, reason: substantive examination [2004/47]
20.11.2001Minutes of oral proceedings despatched
30.11.2001Application refused, date of legal effect [2004/47]
Appeal following examination15.01.2002Appeal received No.  T0497/02
19.03.2002Statement of grounds filed
27.05.2004Result of appeal procedure: appeal of the applicant was rejected
27.05.2004Date of oral proceedings
07.06.2004Minutes of oral proceedings despatched
Parent application(s)   TooltipEP87903195.3  / EP0305387
Divisional application(s)EP04076529.9  / EP1498425
Fees paidRenewal fee
11.11.1993Renewal fee patent year 03
11.11.1993Renewal fee patent year 04
11.11.1993Renewal fee patent year 05
11.11.1993Renewal fee patent year 06
11.11.1993Renewal fee patent year 07
09.05.1994Renewal fee patent year 08
27.04.1995Renewal fee patent year 09
09.05.1996Renewal fee patent year 10
12.05.1997Renewal fee patent year 11
11.05.1998Renewal fee patent year 12
06.05.1999Renewal fee patent year 13
08.05.2000Renewal fee patent year 14
10.05.2001Renewal fee patent year 15
06.05.2002Renewal fee patent year 16
07.05.2003Renewal fee patent year 17
05.05.2004Renewal fee patent year 18
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]  - Medline database, abstract number 86056688, WE Schmidt et al., " Glucagon-like peptide-1, but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets" [X] 1,2,4-9
    [ ] - Diabetologia, 28(9), Sept. 1985, pages 704-707
 [A]  - Medline database, abstract 85155044, M. Ghiglione et al. "How glucagon-like is glucagon-like peptide-1?" & Diabetologia, 27(6), Dec. 1984, pages 599-600 [A] 1-9
 [PX]  - Medline datbase, abstract 87109809, S. Mojsov etal. "Insulinotropin: glucagon-like peptide-1 (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the [PX] 1-9
    [ ] - perfused rat pancreas" & J. Clin. Invest., Feb. 1987, 79(2), pages 616-619
 [PX]  - T W SCHWARZ ET AL., "The processing of peptide precursors", FEBS LETTERS., AMSTERDAM NL, (19860505), vol. 200, no. 1, pages 1 - 10 [PX] 1-3 * page 7, lines 3-24 * * figure 3 *
 [PX]  - JJ HOLST ET AL., "truncated glucagone-like peptide I, an insulin-releasing hormone from the distal gut", FEBS LETTERS., AMSTERDAM NL, (198701), vol. 211, no. 2, pages 169 - 174 [PX] 1-9 * page 170, section 2.3; pages 171-172 *
 [PX]  - D J DRUCKER ET AL., "Cell-specific post-translational processing of preproglucagon expressed from a metallothionein-glucagon fusion gene", JOURNAL OF BIOLOGICAL CHEMISTRY., BALTIMORE US, (19860725), vol. 261, no. 21, pages 9637 - 9643, XP000985097 [PX] 1-9 *page 9637, abstract and column 2, last two paragraphs; page 9641, especially fig. 5*
otherWO8706941
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.